Healthcare Experience

Brand Institute Healthcare Share of Market


Our Healthcare experience includes 584 clients, with 2,262 partnered brands and 445 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.



CLIENTS BRANDS CATEGORY
E5 PHARMA ORAXYL Antibiotic
E5 PHARMA TREZIX Pain & Inflammation
E5 PHARMA TREZIX Pain & Inflammation
EA PHARMA carotegrast Immunology
EA PHARMA ATEDIO Cardiovascular
EAGLE PHARMACEUTICALS BENDEKA * Oncology
EDWARDS LIFESCIENCES MONARC Medical Device
EDWARDS LIFESCIENCES ASCENDRA Medical Device
EDWARDS LIFESCIENCES RETROFLEX Medical Device
EGALET ARYMO ER *
EISAI BELVIQ XR * Endocrinology
EISAI KISPLYX Oncology
EISAI ACIPHEX Gastrointestinal
EISAI ARICEPT ODT Neurology
EISAI BANZEL Neurology
EISAI INOVELON (イノベロン) Neurology
EISAI LUSEDRA Neurology
EISAI ACIPHEX Product Identity
EISAI atopaxar Cardiovascular
EISAI atopaxar hydrobromide Cardiovascular
EISAI ALOXI * Gastrointestinal
EISAI DACOGEN Oncology
EISAI amolimogene bepiplasmid Antiviral
EISAI lemborexant Neurology
EISAI LENVIMA Oncology
EISAI BELVIQ * Obesity
EISAI FYCOMPA Neurology
EISAI ZONEGRAN Neurology
EISAI HALAVEN Oncology
EISAI avatrombopag Hematology
EISAI avatrombopag maleate Hematology
ELAN PHARMACEUTICALS PRIALT Pain & Inflammation
ELAN PHARMACEUTICALS TYSABRI Immunology
ELANCO INTERCEPTOR Veterinary
ELANCO TRIFEXIS Veterinary
ELI LILLY AMYVID * Neurology
ELI LILLY pegbovigrastim Veterinary
ELI LILLY SYMBYAX Neurology
ELI LILLY AXIRON Men's Health
ELI LILLY PORTRAZZA Oncology
ELI LILLY BYETTA * Endocrinology
ELI LILLY CYMBALTA Neurology
ELI LILLY EFFIENT Cardiovascular
ELI LILLY PROZAC WEEKLY * Neurology
ELI LILLY SARAFEM Neurology
ELI LILLY STRATTERA Neurology
ELI LILLY TRILOGY ACS Clinical Trial Name
ELI LILLY XIGRIS Antibiotic
ELUSYS obiltoxaximab Immunology
ELUSYS ANTHIM Immunology
EMERGENT BIOSOLUTIONS ANTHRASIL Immunology
EMERGENT BIOSOLUTIONS MIRACYTE Medical Device
ENANTA PHARMACEUTICALS modithromycin Antibiotic
ENDO PHARMACEUTICALS DEPODUR Pain & Inflammation
ENDO PHARMACEUTICALS OPANA Pain & Inflammation
ENDO PHARMACEUTICALS OPANA ER Pain & Inflammation
ENDO PHARMACEUTICALS TREVOLON Pain & Inflammation
ENDO PHARMACEUTICALS SANCTURA XR * Urology
ENDO PHARMACEUTICALS XIAFLEX * Musculoskeletal
ENDO PHARMACEUTICALS NEBIDO Endocrinology
ENDO PHARMACEUTICALS SANCTURA * Urology
ENDO PHARMACEUTICALS XIAPEX Musculoskeletal
ENDO PHARMACEUTICALS AVEED Endocrinology
ENDO PHARMACEUTICALS BELBUCA Pain & Inflammation
ENDO PHARMACEUTICALS ASTORA HEALTH Corporate Identity
ENDOCEUTICS INTRAROSA * Women's Health
ENTRIGUE VENTERA SINUS DILATION SYSTEM Medical Device
ENTRIGUE SYNAERO Medical Device
ENZYMERX pegadricase Cardiovascular
EPIZYME pinometostat Oncology
EPIZYME tazemetostat Oncology
ERIMOS PHARMACEUTICALS terameprocol Oncology
ESPERION bempedoic acid Cardiovascular
ESPERO PHARMACEUTICALS GONITRO Cardiovascular
ESSILOR TREXA Ophthalmology
ESSILOR ESSILOR 360° LENSES Ophthalmology
ETHICON SECURESTRAP Medical Device
ETHICON EVARREST Medical Device
ETHICON STRATAFIX Medical Device
ETHICON DERMABOND ADVANCED Medical Device
ETHICON DERMABOND Medical Device
ETHICON EVICEL Medical Device
ETHICON PHYSIOMESH Medical Device
ETHICON PRINEO Medical Device
ETHICON EVERPOINT Medical Device
ETHICON QUALTRUS Corporate Identity
EXACT SCIENCES COLOGUARD Medical Device
EXAGEN COPERNA Medical Device
EXELIXIS cabozantinib Oncology


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMA, and/or Health Canada, and other Regulatory Agencies.

Back to top